The effects of anticonvulsants on 4-aminopyridine-induced bursting: In vitro studies on rat peripheral nerve and dorsal roots

British Journal of Pharmacology

Volumn 117, Issue 3, 1996, Pages 573-579

  Lees, G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Action potentials; Aminopyridines (4 AP); Carbamazepine; Dorsal roots; Electrophysiology; Lamotrigine; Multiple sclerosis; Phenytoin; Rat sciatic nerve; Toxicity

Indexed keywords

4 AMINOPYRIDINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN;

AFTERDISCHARGE; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DORSAL ROOT; DORSAL ROOT POTENTIAL; MALE; NERVE POTENTIAL; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; TEMPERATURE SENSITIVITY;

EID: 0030045193     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15229.x     Document Type: Article

References (40)

1. BALL, A.P., HOPKINSON, R.B., FARRELL, I.D., HUTCHISON, J.G.P., PAUL, R., WATSON, R.D.S., PAGE, A.J.F., PARKER, R.G.F., EDWARDS, C.W., SNOW, M., SCOTT, D.K., LEONE-GANADO, A., HASTINGS, A., GHOSH, A.C. & R.J. GILBERT. (1979). Human botulism caused by clostridium botulinum type E: the Birmingham outbreak. Q. J. Med., 191, 473-491.
2. BEAR, J. & LOTHMAN, E.W. (1993). An in vitro study of focal epileptogenesis in combined hippocampal-parahippocampal slices. Epilepsy Res., 14, 183-93.
3. BEVER, JR, C.T., LESLIE, J., CAMENGA, D.L., PANITCH, H.S. & JOHNSON, K.P. (1990). Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis. Ann. Neurol., 27 (4), 421-427.
4. BLACK, J.A., KOCSIS, J.D. & WAXMAN, S.G. (1990). Ion channel organization of the myelinated fibre. Trends Neurosci., 13, 48-54.
5. BOSTOCK, H. & GRAFF., P. (1985). Activity dependent excitability changes in normal and demyelinated rat spinal root axons. J. Physiol., 365, 239-57.
6. BOSTOCK, H., SEARS, T.A. & SHERRATT, R.M. (1981). The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres. J. Physiol., 313, 301-305.
7. BOSTOCK, H., SHERRATT, R.M. & SEARS, T.A. (1978). Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials. Nature, 274, 385-387.
8. BOWE, C.M., KOCSIS, J.D., TARG, E.F. & WAXMAN, S.G. (1987). Physiological effects of 4-aminopyridine on demyelinated mammalian motor and sensory fibers. Ann. Neurol., 22, 264-268.
9. + channels: local anaesthetics, antiarrythmics and anticonvulsants. Trends Pharmacol. Sci., 8, 57-65.
10. CHEUNG, H., KAMP, D. & HARRIS, M. (1992). An in vitro investigation of the action of lamotrigine on neuronol voltage-activated sodium channels. Epilepsy Res., 13, 107-112.
11. CHIU, S.Y. & RITCHIE, J.M. (1981). Evidence for the presence of potassium channels in the paranodal region of acutely demyelinated mammalian single nerve fibres. J. Physiol., 313, 415-437.
12. CRANMER, C.L., STAGNITTO, M.L., KNOWLES, M.A. & PALMER, G.C. (1994). Kainic acid and 4-aminopyridine seizure models in mice: evaluation of efficacy of anti-epileptic agents and calcium antagonists. Life-Sci., 54, 271-5.
13. DAVIS, F.A., STEFOSKI, D. & RUSH, J. (1990). Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Ann. Neurol., 27, 186-192.
14. ENG, D.L., GORDON, T.R., KOCSIS, J.D. & WAXMAN, S.G. (1988). Development of 4-AP and TEA sensitivities in mammalian myelinated nerve fibres. J. Neurophysiol., 60, 2168-2179.
15. FUETA, Y. & AVOLI, M. (1992). Effects of antiepileptic drugs on 4-aminopyridine-induced epileptiform activity in young and adult rat hippocampus. Epilepsy Res., 12, 207-15.
16. GOLDMAN, L., HAHIN, R. & BEGENISICH, T. (1975). Sodium flux, action potential and temperature dependence. Nature, 257, 516-517.
17. JENSEN, M.S., AZOUZ, R. & YAARI, Y. (1994). Variant firing patterns in rat hippocampal pyramidal cells modulated by extracellular potassium. J. Neurophysiol., 71, 831-9.
18. JOHNS, T. & BERNARD, C. (1994). Research directed towards understanding MS- an overview. Mult. Scler. News, 156, 24-26.
19. JONES, R.E., HERON, J.R., FOSTER, D.H., SNELGAR, R.H. & MASON, R.J. (1983), Effects of 4-aminopyridine in patients with multiple sclerosis. J. Neurol. Sci., 60, 353-362.
20. KAPETANOVIC, I.M., YONEKAWA, I.M. & KUPFERBERG, H.J. (1995). The effects of anticonvulsant compounds on 4-aminopyridine-induced de-novo synthesis of neurotransmitter amino acids in rat hippocampus in vitro. Epilepsy Res., 20, 113-20.
21. LANG, D.G., WANG, C.M. & COOPER, B.R. (1993). Lamotrigine, phenytoin and carbamezepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J. Pharmacol. Exp. Ther., 266, 829-835.
22. LEES, G. & LEACH, M.J. (1993). Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res., 612, 190-199.
23. MACDONALD, R.L. & MCLEAN, M.J. (1986). Anticonvulsant drugs: mechanisms of action. Ad. Neurol., 44, 713-736.
24. MATHEWS, B. (1993). Multiple Sclerosis: the Facts, 3rd edition. Oxford University Press.
25. MURRAY, N.M.F. & NEWSOM-DAVIS, J. (1981). Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission. Neurology (Ny), 31, 265-271.
26. POLMAN, C.H., BERTELSMANN, F.W., DE-WAAL, R., VAN-DIEMEN, H.A., UITDEHAAG, B.M., VAN-LOENEN, A.C. & KOETSIER, J.C. (1994). 4-aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis. Arch. Neurol., 51, 1136-9.
27. REINGOLD, S. (1994). Clinical research and trials-looking at clinical trials of new therapeutic agents and research to develop treatments for MS. Mult. Scler. News, 156, 17-18.
28. ROPER, J. & SCHWARZ, J.R. (1989). Heterogeneous distribution of fast and slow potassium channels in myelinated rat nerve fibres. J. Physiol., 416, 93-110.
29. ROSENBLUTH, J. (1990). Axolemmal abnormalities in myelin mutants. Ann. N.Y. Acad. Sci., 605, 194-214.
30. SALGADO, V.L. (1990). Mode of action of insecticidal dihydropyrazoles: selective block of impulse generation in sensory nerves. Pestic. Sci., 28, 389-411.
31. + channels to 4-aminopyridine and TEA. Experientia, 43, 405-408.
32. SCHAUF, C.L. (1987b). Amantadine restores impulse conduction across demyelinated nerve segments. Clin. Exp. Pharmacol. Physiol., 14, 273-281.
33. SCHAUF, C.L. & DAVIS, F.A. (1974). Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents. J. Neurol. Neurosurg. Psychiatry, 37, 152-161.
34. STEFOSKI, D., DAVIS, F.A., FAUT, M. & SCHAUE, C.L. (1987). 4-Aminopyridine improves clinical signs in multiple sclerosis. Ann. Neurol., 21, 71-77.
35. STEFOSKI, D., DAVIS, F.A., FITZSIMMONS, W.E., LUSKIN, S.S., RUSH, J. & PARKHURST, G.W. (1991). 4-Aminopyridine in multiple sclerosis: prolonged administration. Neurology, 41, 1344-8.
36. TARG, E.F. & KOCSIS, J.D. (1985). 4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve. Brain Res., 328, 358-361.
37. VAN DIEMEN, H.A.M., POLMAN, C.H., VAN DONGEN, T.M.M.M., VAN LOENEN, A.C., NAUTA, J.J.P., TAPHOORN, M.J.B., VAN WALBEEK, H.K. & KOETSIER, J.C. (1992). The effect of 4-aminopyridine on clinical signs in multiple sclerosis: a randomized, placebo-controlled, double-blind, cross-over study. Ann. Neurol., 32, 123-130.
38. WATTS, A.E. & JEFFRYS, J.G. (1993). Effects of carbamazepine and baclofen on 4-aminopyridine-induced epileptic activity in rat hippocampal slices. Br. J. Pharmacol., 108, 819-23.
39. WAXMAN, S.G. (1981). Clinicopathological correlations in multiple sclerosis and related diseases. Adv. Neurol., 31, 169-182.
40. YAMAGUCHI, S. & ROGAWSKI, M.A. (1992). Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res., 11, 9-16.